[{"Assets_0_Q3_USD":737925000.0,"CommonStockSharesOutstanding_0_Q3_shares":49175422.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-233120000.0,"NetIncomeLoss_1_Q3_USD":-94275000.0,"NetIncomeLoss_3_Q3_USD":-281363000.0,"StockholdersEquity_0_Q3_USD":516344000.0,"Ticker":"BPMC","CIK":"1597264","name":"BLUEPRINT MEDICINES CORP","OfficialName":"Blueprint Medicines Corporation Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3980842399.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191105"}]